Literature DB >> 1294939

Mode of action of fibrates.

A L Catapano1.   

Abstract

Fibrates are a class of hypolipidaemic drugs that effectively reduce plasma triglyceride and cholesterol levels, but also raise HDL cholesterol. In recent years the attention of pharmacologists and clinicians to fibrates has been renewed also in the light of a multifaceted action on plasma lipids as well as on factors modulating the thrombotic homeostasis in blood. The mechanisms of actions underlying these effects are discussed in this short review.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1294939     DOI: 10.1016/1043-6618(92)90232-z

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  8 in total

1.  Different effects of fibrates on the microsomal fatty acid chain elongation and the acyl composition of phospholipids in guinea-pigs.

Authors:  M Vázquez; M Alegret; M López; C Rodríguez; T Adzet; M Merlos; J C Laguna
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

2.  Fenofibrate administration does not affect muscle triglyceride concentration or insulin sensitivity in humans.

Authors:  Leigh Perreault; Bryan C Bergman; Devon M Hunerdosse; David J Howard; Robert H Eckel
Journal:  Metabolism       Date:  2011-02-08       Impact factor: 8.694

3.  Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma.

Authors:  S A Kliewer; S S Sundseth; S A Jones; P J Brown; G B Wisely; C S Koble; P Devchand; W Wahli; T M Willson; J M Lenhard; J M Lehmann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

4.  Differential effects of fibrates on the acyl composition of microsomal phospholipids in rats.

Authors:  M Vázquez; S Muñoz; M Alegret; T Adzet; M Merlos; J C Laguna
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

5.  Selective modification of rat hepatic microsomal fatty acid chain elongation and desaturation by fibrates: relationship with peroxisome proliferation.

Authors:  M Alegret; E Cerqueda; R Ferrando; M Vázquez; R M Sánchez; T Adzet; M Merlos; J C Laguna
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

6.  The effects of clofibrate and bezafibrate on cholesterol metabolism in the liver of the male rat.

Authors:  J H Shand; D W West
Journal:  Lipids       Date:  1994-11       Impact factor: 1.880

Review 7.  The role of peroxisome proliferator-activated receptors in healthy and diseased eyes.

Authors:  Paulina Escandon; Brenda Vasini; Amy E Whelchel; Sarah E Nicholas; H Greg Matlock; Jian-Xing Ma; Dimitrios Karamichos
Journal:  Exp Eye Res       Date:  2021-05-16       Impact factor: 3.770

8.  Treatment of lactating sows with clofibrate as a synthetic agonist of PPARα does not influence milk fat content and gains of litters.

Authors:  Denise K Gessner; Birthe Gröne; Susann Rosenbaum; Erika Most; Sonja Hillen; Sabrina Becker; Georg Erhardt; Gerald Reiner; Klaus Eder
Journal:  BMC Vet Res       Date:  2015-03-07       Impact factor: 2.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.